Kewaunee Scientific Corporation files regulatory reports that document operating results, governance actions and material corporate disclosures for its laboratory furniture and biosafety products business. Recent Form 8-K reports cover earnings releases, fiscal-quarter financial condition disclosures, non-GAAP reconciliations, earnings announcement notices, and Regulation FD investor presentation materials.
The company's filings also disclose shareholder voting results, director appointments, auditor ratification, advisory compensation votes, and the registered common stock traded under KEQU on The Nasdaq Global Market. Business descriptions in the filings identify Kewaunee's laboratory casework, fume hoods, modular systems, workstations, benches, biological safety cabinets, epoxy resin surfaces and sinks, and Nu Aire laboratory products.
Kewaunee Scientific Corp. (KEQU) – Form 4 filed 07/28/2025 reports two open-market sales by CFO Donald T. Gardner III on 07/24/2025.
- Sold 2,096 common shares at a weighted avg. $58.34 (range $58.00-$58.97).
- Sold 904 common shares at a weighted avg. $59.18 (range $59.00-$59.45).
- Total shares sold: 3,000; estimated proceeds ≈ $175k.
- Direct ownership dropped from 17,564 to 14,564 shares, a reduction of roughly 17%.
No derivative transactions were reported and the filing offers no commentary on the purpose of the sales.
Kewaunee Scientific Corp. (KEQU) – Form 144 filing: an unidentified insider intends to sell up to 3,000 common shares through Fidelity Brokerage Services on or about 07/23/2025 via Nasdaq. At the recent reference price, the proposed sale is valued at $174,750.
The company has 2,844,290 shares outstanding, so the sale represents roughly 0.1 % of total shares. The seller acquired the stock on 06/23/2023 as a stock-award compensation; no cash purchase was involved, and there have been no other sales in the past three months. The filer certifies that no non-public, material adverse information is known.
While Form 144 notices are routine, any insider disposition can influence sentiment. Given the small size relative to float and absence of other sales, the filing is unlikely to be materially impactful for KEQU’s fundamentals.